{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:23Z","timestamp":1791724703190,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To date, diagnosis of schizophrenia is still based on clinical interviews and careful observations, which is subjective and variable, and can lead to misdiagnosis and\/or delay in diagnosis. As early intervention in schizophrenia is important in improving outcomes, objective tests that can be used for schizophrenia diagnosis or treatment monitoring are thus in great need. MicroRNAs (miRNAs) negatively regulate target gene expression and their biogenesis is tightly controlled by various factors including transcription factors (TFs). Dysregulation of miRNAs in brain tissue and peripheral blood mononuclear cells (PBMNCs) from patients with schizophrenia has been well documented, but analysis of the sensitivity and specificity for potential diagnostic utility of these alternations is limited. In this study, we explored the TF-miRNA-30-target gene axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring. Using bioinformatics analysis, we retrieved all TFs that control the biogenesis of miRNA 30 members as well as all target genes that are regulated by miRNA-30 members. Further, reverse transcription-quantitative PCR analysis revealed that the early growth response protein 1 (EGR1) and miR-30a-5p were remarkably downregulated, whereas neurogenic differentiation factor 1 (NEUROD1) was significantly upregulated in PBMNCs from patients in acute psychotic state. Antipsychotics treatment resulted in the elevation of EGR1 and miR-30a-5p but the reduction of NEUROD1. Receiver operating characteristic analysis showed that the EGR1-miR-30a-5p-NEUROD1 axis possessed significantly greater diagnostic value than miR-30a-5p alone. Our data suggest the EGR1-miR-30a-5p-NEUROD1 axis might serve as a promising biomarker for diagnosis and treatment monitoring for those patients in acute psychotic state.<\/jats:p>","DOI":"10.1038\/tp.2016.268","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T15:23:56Z","timestamp":1484061836000},"page":"e998-e998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring"],"prefix":"10.1038","volume":"7","author":[{"given":"S","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Y","family":"Shugart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"BFtp2016268_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/epirev\/mxn001","volume":"30","author":"J McGrath","year":"2008","unstructured":"McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30: 67\u201376.","journal-title":"Epidemiol Rev"},{"key":"BFtp2016268_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1192\/bjp.150.5.598","volume":"150","author":"EF Torrey","year":"1987","unstructured":"Torrey EF . Prevalence studies in schizophrenia. Br J Psychiatry 1987; 150: 598\u2013608.","journal-title":"Br J Psychiatry"},{"key":"BFtp2016268_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopsych.2005.03.031","volume":"58","author":"CA Altar","year":"2005","unstructured":"Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85\u201396.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016268_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jnr.20208","volume":"77","author":"C Aston","year":"2004","unstructured":"Aston C, Jiang L, Sokolov BP . Microarray analysis of post-mortem temporal cortex from patients with schizophrenia. J Neurosci Res 2004; 77: 858\u2013866.","journal-title":"J Neurosci Res"},{"key":"BFtp2016268_CR5","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1073\/pnas.081071198","volume":"98","author":"Y Hakak","year":"2001","unstructured":"Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746\u20134751.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2016268_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","volume":"28","author":"K Mirnics","year":"2000","unstructured":"Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53\u201367.","journal-title":"Neuron"},{"key":"BFtp2016268_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0920-9964(01)00377-2","volume":"58","author":"MP Vawter","year":"2002","unstructured":"Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 2002; 58: 11\u201320.","journal-title":"Schizophr Res"},{"key":"BFtp2016268_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jpsychires.2012.08.005","volume":"46","author":"J Perez-Santiago","year":"2012","unstructured":"Perez-Santiago J, Diez-Alarcia R, Callado LF, Zhang JX, Chana G, White CH et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res 2012; 46: 1464\u20131474.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016268_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40\u201368.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/mp.2012.37","volume":"17","author":"M Ayalew","year":"2012","unstructured":"Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 2012; 17: 887\u2013905.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR11","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1371\/journal.pmed.0020212","volume":"2","author":"PF Sullivan","year":"2005","unstructured":"Sullivan PF . The genetics of schizophrenia. PLoS Med 2005; 2: e212.","journal-title":"PLoS Med"},{"key":"BFtp2016268_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/2013\/510402","volume":"35","author":"CS Weickert","year":"2013","unstructured":"Weickert CS, Weickert TW, Pillai A, Buckley PF . Biomarkers in schizophrenia: a brief conceptual consideration. Dis Markers 2013; 35: 3\u20139.","journal-title":"Dis Markers"},{"key":"BFtp2016268_CR13","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","volume":"3","author":"E Holmes","year":"2006","unstructured":"Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006; 3: e327.","journal-title":"PLoS Med"},{"key":"BFtp2016268_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/YCO.0b013e328017f67d","volume":"20","author":"E Killackey","year":"2007","unstructured":"Killackey E, Yung AR . Effectiveness of early intervention in psychosis. Curr Opin Psychiatry 2007; 20: 121\u2013125.","journal-title":"Curr Opin Psychiatry"},{"key":"BFtp2016268_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0269881114566631","volume":"29","author":"BS Pickard","year":"2015","unstructured":"Pickard BS . Schizophrenia biomarkers: translating the descriptive into the diagnostic. J Psychopharmacol 2015; 29: 138\u2013143.","journal-title":"J Psychopharmacol"},{"key":"BFtp2016268_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5498\/wjp.v6.i1.102","volume":"6","author":"CY Lai","year":"2016","unstructured":"Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B . Biomarkers in schizophrenia: a focus on blood based diagnostics and theranostics. World J Psychiatry 2016; 6: 102\u2013117.","journal-title":"World J Psychiatry"},{"key":"BFtp2016268_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/mp.2011.78","volume":"17","author":"E Gardiner","year":"2012","unstructured":"Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry 2012; 17: 827\u2013840.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/mp.2014.117","volume":"20","author":"BS Fernandes","year":"2015","unstructured":"Fernandes BS, Steiner J, Berk M, Molendijk ML, Gonzalez-Pinto A, Turck CW et al. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol Psychiatry 2015; 20: 1108\u20131119.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jocn.2014.08.018","volume":"22","author":"XY Sun","year":"2015","unstructured":"Sun XY, Lu J, Zhang L, Song HT, Zhao L, Fan HM et al. Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. J of Clin Neurosci 2015; 22: 570\u2013574.","journal-title":"J of Clin Neurosci"},{"key":"BFtp2016268_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jpsychires.2007.07.011","volume":"42","author":"Y Yao","year":"2008","unstructured":"Yao Y, Schr\u00f6der J, Karlsson H . Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia. J Psychiatr Res 2008; 42: 639\u2013643.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016268_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00787-006-0560-5","volume":"15","author":"C Mehler-Wex","year":"2006","unstructured":"Mehler-Wex C, Duvigneau JC, Hartl RT, Ben-Shachar D, Warnke A, Gerlach M . Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia? Eur Child Adolesc Psychiatry 2006; 15: 504\u2013507.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"BFtp2016268_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.mp.4001116","volume":"7","author":"N Dror","year":"2002","unstructured":"Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M et al. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 2002; 7: 995\u20131001.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","volume":"75","author":"B Wightman","year":"1993","unstructured":"Wightman B, Ha I, Ruvkun G . Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855\u2013862.","journal-title":"Cell"},{"key":"BFtp2016268_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843\u2013854.","journal-title":"Cell"},{"key":"BFtp2016268_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V . The functions of animal microRNAs. Nature 2004; 431: 350\u2013355.","journal-title":"Nature"},{"key":"BFtp2016268_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati N, Cohen SM . MicroRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175\u2013205.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFtp2016268_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev.genom.8.080706.092351","volume":"8","author":"TC Chang","year":"2007","unstructured":"Chang TC, Mendell JT . MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007; 8: 215\u2013239.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BFtp2016268_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M . Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861\u2013874.","journal-title":"Nat Rev Genet"},{"key":"BFtp2016268_CR29","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/gb-2007-8-2-r27","volume":"8","author":"DO Perkins","year":"2007","unstructured":"Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 2007; 8: R27.","journal-title":"Genome Biol"},{"key":"BFtp2016268_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/hmg\/ddn005","volume":"17","author":"NJ Beveridge","year":"2008","unstructured":"Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17: 1156\u20131168.","journal-title":"Hum Mol Genet"},{"key":"BFtp2016268_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/schbul\/sbq091","volume":"38","author":"N Mellios","year":"2012","unstructured":"Mellios N, Galdzicka M, Ginns E, Baker SP, Rogaev E, Xu J et al. Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull 2012; 38: 433\u2013443.","journal-title":"Schizophr Bull"},{"key":"BFtp2016268_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u2013297.","journal-title":"Cell"},{"key":"BFtp2016268_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2105-10-163","volume":"10","author":"S Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay S, Bhattacharyya M . Analyzing miRNA co-expression networks to explore TF-miRNA regulation. BMC Bioinformatics 2009; 10: 163.","journal-title":"BMC Bioinformatics"},{"key":"BFtp2016268_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/10428190902763517","volume":"50","author":"M Mraz","year":"2009","unstructured":"Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J . MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009; 50: 506\u2013509.","journal-title":"Leuk Lymphoma"},{"key":"BFtp2016268_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.genhosppsych.2013.12.008","volume":"36","author":"H He","year":"2014","unstructured":"He H, Xu G, Sun B, Ouyang H, Dang Y, Guo Y et al. The use of 15-point hypomanic checklist in differentiating bipolar I and bipolar II disorder from major depressive disorder. Gen Hosp Psychiatry 2014; 36: 347\u2013351.","journal-title":"Gen Hosp Psychiatry"},{"key":"BFtp2016268_CR36","doi-asserted-by":"publisher","first-page":"D119","DOI":"10.1093\/nar\/gkp803","volume":"38","author":"J Wang","year":"2010","unstructured":"Wang J, Lu M, Qiu C, Cui Q . TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res 2010; 38: D119\u2013D122.","journal-title":"Nucleic Acids Res"},{"key":"BFtp2016268_CR37","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res 2014; 42: e133.","journal-title":"Nucleic Acids Res"},{"key":"BFtp2016268_CR38","first-page":"Unit7.1","volume":"Chapter 7","author":"IJ Fuss","year":"2009","unstructured":"Fuss IJ, Kanof ME, Smith PD, Zola H . Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 2009; Chapter 7: Unit7.1.","journal-title":"Curr Protoc Immunol"},{"key":"BFtp2016268_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","volume":"28","author":"A Gladkevich","year":"2004","unstructured":"Gladkevich A, Kauffman HF, Korf J . Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 559\u2013576.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2016268_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.mp.4001643","volume":"10","author":"A Marques-Deak","year":"2005","unstructured":"Marques-Deak A, Cizza G, Sternberg E . Brain-immune interactions and disease susceptibility. Mol Psychiatry 2005; 10: 239\u2013250.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016268_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","volume":"167","author":"AS Brown","year":"2010","unstructured":"Brown AS, Derkits EJ . Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167: 261\u2013280.","journal-title":"Am J Psychiatry"},{"key":"BFtp2016268_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.schres.2007.11.018","volume":"99","author":"SH Fatemi","year":"2008","unstructured":"Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 2008; 99: 56\u201370.","journal-title":"Schizophr Res"},{"key":"BFtp2016268_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","volume":"27","author":"RD Strous","year":"2006","unstructured":"Strous RD, Shoenfeld Y . Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 2006; 27: 71\u201380.","journal-title":"J Autoimmun"},{"key":"BFtp2016268_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/CMR.8.1.131","volume":"8","author":"RH Yolken","year":"1995","unstructured":"Yolken RH, Torrey EF . Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131\u2013145.","journal-title":"Clin Microbiol Rev"},{"key":"BFtp2016268_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40303-014-0006-9","volume":"2","author":"S Akarsu","year":"2014","unstructured":"Akarsu S, Torun D, Bolu A, Erdem M, Kozan S, Ak M et al. Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features. J Mol Psychiatry 2014; 2: 6.","journal-title":"J Mol Psychiatry"},{"key":"BFtp2016268_CR46","doi-asserted-by":"publisher","first-page":"e32618","DOI":"10.1371\/journal.pone.0032618","volume":"7","author":"NJ van Beveren","year":"2012","unstructured":"van Beveren NJ, Buitendijk GH, Swagemakers S, Krab LC, R\u00f6der C, de Haan L et al. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS One 2012; 7: e32618.","journal-title":"PLoS One"},{"key":"BFtp2016268_CR47","doi-asserted-by":"publisher","first-page":"e21635","DOI":"10.1371\/journal.pone.0021635","volume":"6","author":"CY Lai","year":"2011","unstructured":"Lai CY, Yu SL, Hsieh MH, Chen CH, Chen HY, Wen CC et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 2011; 6: e21635.","journal-title":"PLoS One"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2016268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016268","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:33:20Z","timestamp":1671726800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2016268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["BFtp2016268"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.268","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]},"assertion":[{"value":"15 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}